Robust designs in longitudinal studies accounting for parameter and model uncertainties -Application to count data

Archive ouverte

Loingeville, Florence | Nguyen, Thu Thuy | Riviere, Marie-Karelle | Mentré, France

Edité par CCSD ; Taylor & Francis -

International audience. Nonlinear mixed effect models (NLMEMs) are widely used for the analysis of longitudinal data. To design these studies, optimal designs based on the expected Fisher information matrix (FIM) can be used. A method evaluating the FIM using Monte-Carlo Hamiltonian Monte-Carlo (MC-HMC) has been proposed and implemented in the R package MIXFIM using Stan. This approach, however, requires a priori knowledge of models and parameters, which leads to locally optimal designs. The objective of this work was to extend this MC-HMC-based method to evaluate the FIM in NLMEMs accounting for uncertainty in parameters and in models. When introducing uncertainty in the population parameters, we evaluated the robust FIM as the expectation of the FIM computed by MC-HMC over the distribution of these parameters. Then, the compound D-optimality criterion (CD optimality), corresponding to a weighted product of the D-optimality criteria of several candidate models, was used to find a common CD-optimal design for the set of candidate models. Finally, a compound DE-criterion (CDE optimality), corresponding to a weighted product of the normalized determinants of the robust FIMs of all the candidate models accounting for uncertainty inparameters, was calculated to find the CDE-optimal design which was robust on both parameters and model. These methods were applied in a longitudinal Poisson count model. We assumed prior distributions on the population parameters as well as several candidate models describing the relationship between the logarithm of the event rate parameter and the dose. We found that assuming uncertainty in parameters could lead to different optimal designs, and misspecification of models could induce designs with low efficiencies. The CD- or CDE-optimal designs therefore provided a good compromise for different candidate models. Finally, the proposed approach allows for the first time optimization of designs for repeated discrete data accounting for parameter and model uncertainties.

Suggestions

Du même auteur

Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies

Archive ouverte | Tardivon, Coralie | CCSD

International audience. Abstract In a traditional pharmacokinetic (PK) bioequivalence (BE) study, a two‐way crossover study is conducted, PK parameters (namely the area under the time‐concentration curve [AUC] and t...

Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1

Archive ouverte | Berger, Juliette | CCSD

International audience

Evaluation et optimisation des protocoles de prélèvements dans les études pharmacocinétiques en crossover analysées par des modèles non linéaires à effets mixtes

Archive ouverte | Nguyen, Thu Thuy | CCSD

International audience. Les modèles non linéaires à effets mixtes peuvent être utilisés pour analyser les essais pharmacocinétiques de bioéquivalence ou d'interaction en crossover. En amont de la modélisation se pos...

Chargement des enrichissements...